Digest Réseau Comment ça marche
Réseau
/
Sociétés
JC
Non vérifié

JCR Pharmaceuticals Co., Ltd.

Ce que nous écrivons

BiotechnologieIndustrieIndustrie pharmaceutiqueSantéScience

43 communiqués de presse

Voir tous les communiqués de presse
02/10/2026
Multimédia
Marché du travail
Industrie
Santé
Biotechnologie
Santé Publique
Science
Industrie pharmaceutique
Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for the Development and Potential Commercialization of Novel Investigational Therapy for Hunter Syndrome in the United States, Europe, and Latin America
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
28/09/2026
Industrie
Science
Biotechnologie
Médecine - Divers
Santé
Industrie pharmaceutique
JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
11/09/2026
Multimédia
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé
Médecine - Divers
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for Mucopolysaccharidosis Type IIIB
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
21/07/2026
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé
Médecine - Divers
JCR Pharmaceuticals Receives Marketing Authorization in the United Arab Emirates for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
17/06/2026
Marché du travail
Industrie
Science
Biotechnologie
Industrie pharmaceutique
Santé
JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
08/06/2026
Expos
Industrie
Science
Hygiène alimentaire
Médecine - Divers
Biotechnologie
Santé
Industrie pharmaceutique
Santé Publique
JCR Pharmaceuticals’ Research Presentations at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
28/05/2026
Science
Biotechnologie
Industrie pharmaceutique
Santé Publique
Santé
Hygiène alimentaire
Médecine - Divers
Événements
Expos
Industrie
JCR Pharmaceuticals to Present at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
18/05/2026
Événements
Industrie
Santé
Biotechnologie
Médecine - Divers
Science
Industrie pharmaceutique
JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising Central Nervous System Uptake at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
11/05/2026
Événements
Science
Biotechnologie
Industrie pharmaceutique
Santé
Médecine - Divers
JCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0
05/02/2026
Événements
Finance
Industrie
Santé
Santé Publique
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
Source
JCR Pharmaceuticals Co., Ltd.
Émetteur
Business Wire
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0